glutamic acid has been researched along with triazoles in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.45) | 18.7374 |
| 1990's | 5 (7.25) | 18.2507 |
| 2000's | 36 (52.17) | 29.6817 |
| 2010's | 23 (33.33) | 24.3611 |
| 2020's | 4 (5.80) | 2.80 |
| Authors | Studies |
|---|---|
| O'Regan, MH; Perkins, LM; Phillis, JW; Simpson, RE | 1 |
| Baud, J; Benedict, M; Bischoff, S; Bittiger, H; Fagg, GE; Hauser, K; Meier, R; Portet, C; Schmutz, M; Thedinga, K | 1 |
| Feuerstein, G; Jiang, ZG; Yue, TL | 1 |
| Damani, LA; Kadaba, PK; P-Nnane, I; Stevenson, PJ | 1 |
| Araújo, C; Catelli, M; Cordeiro, R; Estato, V; Lopes-Martins, R; Tibiriçá, E | 1 |
| Davis, SC; Dierks, EA; Ortiz de Montellano, PR | 1 |
| Agostinho, P; Cunha, RA; Melo, J; Oliveira, CR; Rego, AC | 1 |
| Gao, ZG; Ijzerman, AP; Jacobson, KA; Jiang, Q | 1 |
| Bianchi, L; Corsi, C; Melani, A; Pedata, F | 1 |
| Pèzzola, A; Pintor, A; Popoli, P; Quarta, D; Reggio, R | 2 |
| Domenici, MR; Falchi, M; Frank, C; Malchiodi-Albedi, F; Massotti, M; Pèzzola, A; Pintor, A; Popoli, P; Quarta, D; Reggio, R; Scarchilli, L; Tebano, MT | 1 |
| Bonfanti, A; Marchi, M; Monopoli, A; Ongini, E; Raiteri, L; Raiteri, M; Risso, F; Vallarino, A | 1 |
| Cunha, RA; Fredholm, BB; Kull, B; Lopes, LV; Ribeiro, JA | 1 |
| Ferré, S; Goldberg, SR; Karcz-Kubicha, M; Popoli, P; Solinas, M; You, ZB | 1 |
| D'Ambrosio, R; Iliff, JJ; Ngai, AC; Winn, HR | 1 |
| Corsi, C; Gianfriddo, M; Melani, A; Morelli, M; Pedata, F; Pinna, A | 1 |
| Boehm, S; Freissmuth, M; Just, H; Klinger, M; Korkhov, VM; Kudlacek, O; Nanoff, C; Pankevych, H; Vartian, N; Yang, Q | 1 |
| Corsi, C; Gianfriddo, M; Melani, A; Pedata, F; Pèzzola, A; Popoli, P; Reggio, R | 1 |
| Domenici, MR; Frank, C; Nazzicone, V; Pèzzola, A; Pintor, A; Popoli, P; Potenza, RL; Reggio, R; Tebano, MT | 1 |
| Galluzzo, M; Grieco, R; Pèzzola, A; Pintor, A; Popoli, P; Reggio, R | 1 |
| Domenici, MR; Frank, C; Grieco, R; Martire, A; Pepponi, R; Pintor, A; Popoli, P; Potenza, RL; Tebano, MT | 1 |
| Gianfriddo, M; Giovannini, MG; Melani, A; Pedata, F; Turchi, D | 1 |
| Bonfanti, A; Chiaramonte, G; Marcoli, M; Maura, G; Ongini, E; Raiteri, M; Roccatagliata, P | 1 |
| Alfaro, TM; Cunha, RA; Oliveira, CR; Rebola, N; Rodrigues, RJ | 1 |
| Boeck, CR; Bronzatto, MJ; Kroth, EH; Vendite, D | 1 |
| Almeida, T; Cunha, RA; Oliveira, CR; Richardson, PJ; Rodrigues, RJ | 1 |
| Berrino, L; de Novellis, V; Maione, S; Marabese, I; Mariani, L; Oliva, P; Palazzo, E; Rossi, F; Scafuro, M; Siniscalco, D | 1 |
| Angrish, P; Cusido, J; Katritzky, AR; Shestopalov, AA; Todadze, E | 2 |
| Baunez, C; Bernardi, G; Calabresi, P; Centonze, D; De Chiara, V; Gubellini, P; Picconi, B; Prosperetti, C; Rossi, S; Tscherter, A | 1 |
| Jiang, R; Katritzky, AR; Kirichenko, K; Suzuki, K; Tao, H | 1 |
| Azuma, T; Fukuda, J; Hata, M; Hikichi, H; Ito, S; Kaneko, N; Kawagoe-Takaki, H; Kawamoto, H; Kimura, T; Maehara, S; Ohta, H; Sakai, N; Satow, A; Suzuki, G | 1 |
| Adams, CL; Cowen, MS; Lawrence, AJ; Short, JL | 1 |
| Cavalheiro, EA; Naffah-Mazzacoratti, Mda G; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E | 1 |
| Borioni, A; Calamandrei, G; Domenici, MR; Lastoria, G; Martire, A; Popoli, P; Potenza, RL; Scattoni, ML; Venerosi, A | 1 |
| Baranyi, M; Illes, P; Sperlágh, B; Vizi, ES; Zsilla, G | 1 |
| Belcastro, V; Borsini, F; Calabresi, P; Centonze, D; Costa, C; Picconi, B; Tantucci, M; Tozzi, A; Tscherter, A | 1 |
| Borsini, F; Galluzzo, M; Grieco, R; Pèzzola, A; Pintor, A; Popoli, P | 1 |
| Antunes, C; Böhmer, AE; Elisabetsky, E; Lara, DR; Porciúncula, LO; Schallenberger, C; Schmidt, AP; Souza, DO | 1 |
| Ferrante, A; Ferretti, R; Martire, A; Pepponi, R; Popoli, P | 1 |
| Ballerini, P; Biagioni, F; Buccella, S; Caciagli, F; Ciccarelli, R; Citraro, R; D'Alimonte, I; D'Auro, M; De Sarro, G; Di Iorio, P; Giuliani, P; Jiang, S; Nargi, E; Russo, E | 1 |
| Ferguson, AL; Stone, TW | 1 |
| Chang, HW; Kim, KH; Kim, SH; Kim, YJ | 1 |
| Agostinho, PM; Canas, PM; Costenla, AR; Cunha, RA; de Mendonça, A; Diógenes, MJ; Maroco, J; Nogueira, C; Ribeiro, JA; Rodrigues, RJ | 1 |
| Dziubina, A; Gołembiowska, K | 2 |
| Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N | 1 |
| Cho, SJ; Gadhe, CG; Kothandan, G | 1 |
| Agostinho, P; Augusto, E; Cunha, RA; dos Santos-Rodrigues, A; Machado, NJ; Matos, M | 1 |
| Dessingou, J; Pathak, RK; Rao, CP | 1 |
| Abreu, PA; Albuquerque, MG; Castro, HC; Caversan, OM; Farias, FM; Ferreira, JM; Giongo, V; Henriques, AM; Leão, RA; Marins, LM; Paes-de-Carvalho, R; Paixão, IC; Pinheiro, S; Rodrigues, CR; Santana, MV | 1 |
| Batalha, VL; Coelho, JE; Diógenes, MJ; Ferreira, DG; Gomes, R; Lopes, LV; Sebastião, AM; Valadas, JS | 1 |
| An, JH; Chen, JF; Dai, SS; Li, W; Ning, YL; Wang, H; Yang, N; Zhou, YG; Zhu, PF | 1 |
| Deshpande, MV; Joshi, CV; Kapadnis, BP; Pathan, EK; Punekar, NS; Tupe, SG | 1 |
| Agostinho, P; Augusto, E; Chen, JF; Cunha, RA; Matos, M | 1 |
| Filip, M; Fuxe, K; Gołembiowska, K; Kamińska, K; Suder, A; Wydra, K | 1 |
| Chen, S; Li, W; Liu, L; Wang, G; Wang, L; Wang, Z; Yang, Q | 1 |
| Chaki, S; Hiyoshi, T; Kambe, D; Karasawa, J | 1 |
| Cristóvão, G; Cunha, RA; George, J; Gomes, CA; Gonçalves, FQ; Gonçalves, T; Meyer Fernandes, JR; Rodrigues, L | 1 |
| Agostinho, P; Augusto, E; Boison, D; Chen, JF; Cunha, RA; Matos, M; Shen, HY; Wang, Y; Wang, YT; Wei, CJ | 1 |
| Niu, Z; Tian, Y; Wu, F; Wu, M; Zhou, Q | 1 |
| Diógenes, MJ; Lérias, SR; Parreira, S; Sebastião, AM; Vaz, SH | 1 |
| Bonnemain, JL; Chollet, JF; Lei, ZW; Marhadour, S; Marivingt-Mounir, C; Wu, H; Yang, W | 1 |
| Chaudhari, N; Dawalbhakta, M; Nampoothiri, L | 1 |
| D'Acunto, CW; Gonzalez, G; Hodoň, J; Kaňovský, P; Kazakova, A; Strnad, M; Urban, M | 1 |
| Bertrand, M; Boutin, JA; Dupuis, P; Ferry, G; Frankiewicz, L; Galibert, M; Gloanec, P; Jullian, M; Ko, A; Le Diguarher, T; Pecquery, A; Puget, K; Ripoll, L | 1 |
| Chollet, JF; Guichard, B; Hu, R; La Camera, S; Marivingt-Mounir, C; Wu, H | 1 |
| Bedi, PMS; Chadha, R; Kaur, J; Kaur, R; Kaur, U; Sharma, A; Singh, A; Singh, K | 1 |
1 review(s) available for glutamic acid and triazoles
| Article | Year |
|---|---|
Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential.
Topics: Alzheimer Disease; Amyloidogenic Proteins; Calcium; Glutamic Acid; Humans; Triazoles | 2023 |
1 trial(s) available for glutamic acid and triazoles
| Article | Year |
|---|---|
Plasma glutamate-modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury.
Topics: Acute Lung Injury; Adenosine; Adenosine A2 Receptor Agonists; Adult; Animals; Bone Marrow Cells; Brain Injuries; Disease Models, Animal; Female; Glutamic Acid; Humans; Male; Mice; Mice, Knockout; Middle Aged; Phenethylamines; Protein Kinase C; Receptor, Adenosine A2A; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Signal Transduction; Triazines; Triazoles; Type C Phospholipases | 2013 |
67 other study(ies) available for glutamic acid and triazoles
| Article | Year |
|---|---|
Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Glutamates; Glutamic Acid; Male; Neurotransmitter Agents; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines | 1992 |
CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain.
Topics: Animals; Anticonvulsants; Binding, Competitive; Brain; Dibenzocycloheptenes; Dizocilpine Maleate; Epilepsy; Glutamates; Glutamic Acid; Mice; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Subcellular Fractions; Triazoles | 1989 |
Platelet-activating factor inhibits excitatory transmission in rat neostriatum.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Azepines; Glutamates; Glutamic Acid; Neostriatum; Neural Inhibition; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinoxalines; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1993 |
Triazolines--XXVII. delta2-1,2,3-triazoline anticonvulsants: novel 'built-in' heterocyclic prodrugs with a unique 'dual-action' mechanism for impairing excitatory amino acid L-glutamate neurotransmission.
Topics: Animals; Anticonvulsants; Binding, Competitive; Brain; Dizocilpine Maleate; Drug Design; Glutamic Acid; Ion Channels; Magnetic Resonance Spectroscopy; Mice; Prodrugs; Radioligand Assay; Rats; Receptors, GABA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Synaptic Transmission; Triazoles | 1996 |
Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
Topics: Animals; Azepines; Blood Pressure; Carotid Arteries; Diterpenes; Enzyme Inhibitors; Female; Ginkgolides; Glutamic Acid; Injections, Intraventricular; Lactones; Male; Muscle Tonus; Norepinephrine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinacrine; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1996 |
Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.
Topics: Amino Acid Substitution; Aspartic Acid; Binding Sites; Catalysis; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Enzyme Activation; Glutamic Acid; Humans; Hydroxylation; Imidazoles; Imines; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Recombinant Proteins; Substrate Specificity; Triazoles | 1998 |
Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells.
Topics: Adenosine; Analysis of Variance; Animals; Aspartic Acid; Bicuculline; Cells, Cultured; Chick Embryo; Chromatography, High Pressure Liquid; Excitatory Amino Acids; Extracellular Space; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Glycolysis; Humans; Ischemia; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Retina; Triazines; Triazoles; Xanthines | 2000 |
Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation.
Topics: Animals; Binding, Competitive; Drug Interactions; Glutamic Acid; Guanosine Triphosphate; Histidine; Humans; In Vitro Techniques; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Sodium; Triazines; Triazoles; Tritium | 2000 |
Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats.
Topics: Adenosine; Age Factors; Aging; Animals; Aspartic Acid; Glutamic Acid; Male; Neostriatum; Neurons; Neuroprotective Agents; Potassium; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Time Factors; Triazoles | 2000 |
The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors.
Topics: Animals; Corpus Striatum; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Male; Microdialysis; Neuroprotective Agents; Phenylacetates; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Purinergic P1; Triazoles | 2000 |
SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
Topics: Animals; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; Male; Microdialysis; Neuroprotective Agents; Potassium; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Time Factors; Triazoles | 2001 |
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Topics: Animals; Behavior, Animal; Calcium; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Excitatory Amino Acid Antagonists; Gliosis; Glutamic Acid; Hippocampus; Huntington Disease; Long-Term Potentiation; Male; Maze Learning; Motor Activity; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazoles | 2002 |
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.
Topics: Adenosine; Analysis of Variance; Animals; Cerebral Cortex; Chromatography, High Pressure Liquid; Glutamic Acid; In Vitro Techniques; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Synaptosomes; Triazoles; Xanthines | 2002 |
Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; In Vitro Techniques; Ligands; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Signal Transduction; Synaptic Transmission; Transfection; Triazines; Triazoles; Xanthines | 2002 |
Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens.
Topics: Animals; Behavior, Animal; Caffeine; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Glutamic Acid; Injections, Intraperitoneal; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Theophylline; Triazoles; Wakefulness | 2002 |
Adenosine receptors mediate glutamate-evoked arteriolar dilation in the rat cerebral cortex.
Topics: Animals; Arterioles; Blood Pressure; Cerebrovascular Circulation; Excitatory Amino Acid Agonists; Glutamic Acid; Male; N-Methylaspartate; Pia Mater; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazines; Triazoles; Vasodilation | 2003 |
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
Topics: Animals; Corpus Striatum; Denervation; Dopamine; Glutamic Acid; Male; Microdialysis; Oxidopamine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Time Factors; Triazoles | 2003 |
The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenine; Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenylyl Cyclases; Animals; Benzamides; Binding, Competitive; Cell Cycle; Cell Membrane; Cofilin 1; Colforsin; Cyclic AMP; Cytoskeletal Proteins; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Activation; Gene Expression; Glutamic Acid; Humans; Membrane Potentials; Patch-Clamp Techniques; PC12 Cells; Pertussis Toxin; Phenethylamines; Phosphodiesterase Inhibitors; Phosphoproteins; Propionates; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrrolidines; Quinpirole; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Purinergic P1; Thionucleotides; Transfection; Triazines; Triazoles; Xenopus Proteins | 2003 |
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Extracellular Space; Glutamic Acid; Huntington Disease; Male; Microdialysis; Models, Animal; Neuroprotective Agents; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Time Factors; Triazoles | 2003 |
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cells, Cultured; Corpus Striatum; Drug Administration Routes; Electric Stimulation; Electroencephalography; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Microdialysis; Motor Activity; Neurons; Neuroprotective Agents; Neurotoxins; Pyrimidines; Quinolinic Acid; Rats; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synapses; Triazoles | 2003 |
Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dicarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Kainic Acid; Male; Microdialysis; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Pyrimidines; Pyrrolidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles | 2004 |
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Calcium; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Models, Biological; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Phenethylamines; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes; Synaptic Transmission; Triazines; Triazoles | 2004 |
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Extracellular Fluid; Glutamic Acid; Huntington Disease; Male; Mice; Mice, Inbred CBA; Mice, Transgenic; Mitogen-Activated Protein Kinases; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2004 |
Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade.
Topics: Adenosine A2 Receptor Antagonists; Adult; Aged; Anesthetics, Local; Aspartic Acid; Brain Ischemia; Calcium; Cerebral Cortex; Female; Glucose; Glutamic Acid; Humans; In Vitro Techniques; Male; Middle Aged; Neuroprotective Agents; Pyrimidines; Reperfusion Injury; Synaptic Vesicles; Tetrodotoxin; Triazoles | 2004 |
Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Neostriatum; Phenethylamines; Presynaptic Terminals; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Subcellular Fractions; Synaptosomes; Triazoles; Xanthines | 2005 |
Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Animals; Animals, Newborn; Cell Death; Cells, Cultured; Cerebellum; Cyclic AMP; Drug Antagonism; Excitatory Amino Acid Agonists; Glutamic Acid; Hydrolysis; N-Methylaspartate; Neurons; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles | 2005 |
Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; Astrocytoma; Calcium; Cell Line; Cell Line, Tumor; Glutamic Acid; Hippocampus; Kidney; Male; Potassium; Pyramidal Cells; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Presynaptic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Recombinant Fusion Proteins; RNA, Messenger; Subcellular Fractions; Suramin; Synaptosomes; Transfection; Triazines; Triazoles; Xanthines | 2005 |
Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia.
Topics: Acetates; Acrylamides; Animals; Benzyl Compounds; Dimethyl Sulfoxide; Extracellular Fluid; Formaldehyde; gamma-Aminobutyric Acid; Glutamic Acid; Hyperalgesia; Injections, Intraventricular; Male; Mice; Microdialysis; Misoprostol; Naphthalenes; Pain Measurement; Periaqueductal Gray; Prostaglandin Antagonists; Receptors, Prostaglandin E; Thiophenes; Triazoles; Xanthones | 2006 |
Selective peptide chain extension at the N-terminus of aspartic and glutamic acids utilizing 1-(N-protected-alpha-aminoacyl)benzotriazoles.
Topics: Aminoacylation; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamic Acid; Magnetic Resonance Spectroscopy; Oligopeptides; Stereoisomerism; Triazoles | 2006 |
Selective peptide chain extension at the C-terminus of aspartic and glutamic acids utilizing N-protected (alpha-aminoacyl)benzotriazoles.
Topics: Aminoacylation; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamic Acid; Magnetic Resonance Spectroscopy; Oligopeptides; Stereoisomerism; Triazoles | 2006 |
Deficits of glutamate transmission in the striatum of experimental hemiballism.
Topics: Anesthetics, Local; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dyskinesias; Electric Stimulation; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Sulpiride; Synaptic Transmission; Tetrodotoxin; Triazines; Triazoles | 2006 |
Novel syntheses of chiral beta- and gamma-amino acid derivatives utilizing N-protected (aminoacyl)benzotriazoles from aspartic and glutamic acids.
Topics: Amino Acids; Aspartic Acid; Glutamic Acid; Molecular Structure; Stereoisomerism; Triazoles | 2007 |
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Topics: Animals; Benzimidazoles; Binding, Competitive; Calcium Signaling; Cell Line; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Inositol Phosphates; Male; Mice; Mice, Inbred ICR; Molecular Structure; Motor Activity; Naphthalenes; Point Mutation; Quisqualic Acid; Rats; Receptors, Metabotropic Glutamate; Thiazoles; Transfection; Triazoles | 2007 |
Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Alcohol Drinking; Animals; Behavior, Animal; Central Nervous System Depressants; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Ethanol; Extinction, Psychological; Glutamic Acid; Models, Animal; Motor Activity; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Reaction Time; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Self Administration; Thiazoles; Time Factors; Triazoles; Xanthines | 2008 |
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Glutamic Acid; Headache Disorders; Headache Disorders, Secondary; Humans; Male; Middle Aged; Migraine Disorders; Piperidines; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2007 |
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Brain; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Huntington Disease; Learning Disabilities; Maze Learning; Mental Disorders; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Organ Culture Techniques; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2007 |
Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
Topics: Adenosine; Adenosine Triphosphate; Analgesics; Animals; Dose-Response Relationship, Drug; Glucose; Glutamic Acid; Hippocampus; Hypoxia; In Vitro Techniques; Ischemia; Male; Phenethylamines; Purinergic Agonists; Purinergic Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptors, Purinergic; Sodium Channel Blockers; Tetrodotoxin; Triazines; Triazoles; Xanthines | 2007 |
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
Topics: Adenine; Adenosine; Animals; Cerebral Cortex; Corpus Striatum; Dopamine Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Phenethylamines; Quinpirole; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Dopamine D2; Synaptic Transmission; Triazines; Triazoles | 2007 |
Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Quinolinic Acid; Rats; Rats, Wistar; Triazoles | 2008 |
Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Allopurinol; Analgesics; Animals; Capsaicin; Dose-Response Relationship, Drug; Glutamic Acid; Hot Temperature; Injections, Intraperitoneal; Male; Mice; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Pyrimidines; Triazoles; Uric Acid; Xanthine Oxidase; Xanthines | 2009 |
Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons.
Topics: Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Biological Transport; Biomimetics; Blotting, Western; Cells, Cultured; Cerebral Cortex; Dicarboxylic Acids; Female; Gene Expression Regulation; Glutamic Acid; Neostriatum; Neurons; Neuroprotective Agents; Organ Specificity; Pregnancy; Pyrrolidines; Rats; Receptor, Adenosine A2A; Substrate Specificity; Triazines; Triazoles | 2009 |
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.
Topics: Adenosine; Age Factors; Analysis of Variance; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Electroencephalography; Epilepsy, Absence; Glutamic Acid; Immunohistochemistry; Male; MAP Kinase Signaling System; Microinjections; Phenethylamines; Pyrimidines; Rats; Receptor, Adenosine A2A; Somatosensory Cortex; Thalamus; Triazoles | 2009 |
Glutamate-induced depression of EPSP-spike coupling in rat hippocampal CA1 neurons and modulation by adenosine receptors.
Topics: Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Animals; CA1 Region, Hippocampal; Drug Interactions; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Neural Inhibition; Neurons; Neuroprotective Agents; Probability; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, N-Methyl-D-Aspartate; Triazoles; Xanthines | 2010 |
Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents.
Topics: Analysis of Variance; Animals; Bioprosthesis; Calcinosis; Calcium; Cattle; Dermis; Ethanol; Female; Fixatives; Glutamic Acid; Glutaral; Hot Temperature; Octanols; Pericardium; Phospholipids; Phosphorus; Rats; Rats, Sprague-Dawley; Solvents; Tensile Strength; Time Factors; Triazoles | 2011 |
Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aging; Animals; Electrophysiology; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Long-Term Potentiation; Male; Memory Disorders; N-Methylaspartate; Neuronal Plasticity; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Synaptic Transmission; Triazoles; Xanthines | 2011 |
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Benserazide; Caffeine; Dopamine; Glutamic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles | 2012 |
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase | 2012 |
The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Caffeine; Corpus Striatum; Dopamine; Dopamine Agents; Extracellular Space; Glutamic Acid; Homovanillic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Oxidative Stress; Rats; Rats, Wistar; Reserpine; Triazines; Triazoles; Vesicular Monoamine Transport Proteins | 2012 |
Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
Topics: Amino Acid Sequence; Benzamides; Binding Sites; Cyclohexanes; Glutamic Acid; Humans; Maraviroc; Models, Molecular; Molecular Dynamics Simulation; Molecular Sequence Data; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidines; Receptors, CCR2; Receptors, CCR5; Sequence Homology, Amino Acid; Triazoles | 2012 |
Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake.
Topics: Adenosine A2 Receptor Antagonists; Amyloid beta-Peptides; Animals; Astrocytes; Cells, Cultured; Down-Regulation; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazoles | 2012 |
Multiple sensor array of Mn2+, Fe2+, Co2+, Ni2+, Cu2+, and Zn2+ complexes of a triazole linked imino-phenol based calix[4]arene conjugate for the selective recognition of Asp, Glu, Cys, and His.
Topics: Aspartic Acid; Calixarenes; Cysteine; Glutamic Acid; Histidine; Imines; Models, Molecular; Molecular Structure; Organometallic Compounds; Phenols; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization; Transition Elements; Triazoles | 2012 |
Molecular modeling of a phenyl-amidine class of NMDA receptor antagonists and the rational design of new triazolyl-amidine derivatives.
Topics: Amidines; Animals; Cell Death; Chlorocebus aethiops; Glutamic Acid; Molecular Docking Simulation; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Retinal Neurons; Structure-Activity Relationship; Triazoles; Vero Cells | 2013 |
Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cerebral Cortex; Corticotropin-Releasing Hormone; Glutamic Acid; Neural Inhibition; Neurons; Neuroprotective Agents; Primary Cell Culture; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Triazoles | 2012 |
A biochemical correlate of dimorphism in a zygomycete Benjaminiella poitrasii: characterization of purified NAD-dependent glutamate dehydrogenase, a target for antifungal agents.
Topics: Ammonium Chloride; Antifungal Agents; Candida albicans; Catalysis; Chromatography, Agarose; Drug Evaluation, Preclinical; Fungal Proteins; Glutamate Dehydrogenase; Glutamic Acid; Histidine; Hyphae; Isoelectric Point; Ketoglutaric Acids; Lysine; Molecular Targeted Therapy; Molecular Weight; Mucorales; NAD; Phosphorylation; Protein Processing, Post-Translational; Substrate Specificity; Triazoles; Yarrowia | 2013 |
Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Aspartic Acid; Astrocytes; Glial Fibrillary Acidic Protein; Glutamic Acid; Immunoprecipitation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ouabain; Phenethylamines; Pyrimidines; Receptor, Adenosine A2A; Sodium-Potassium-Exchanging ATPase; Subcellular Fractions; Triazoles; Tritium | 2013 |
On the role of adenosine (A)₂A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Basal Forebrain; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Male; Nucleus Accumbens; Phenethylamines; Purines; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Reinforcement, Psychology; Reward; Self Administration; Triazoles | 2015 |
Investigation of nonfouling polypeptides of poly(glutamic acid) with lysine side chains synthesized by EDC·HCl/HOBt chemistry.
Topics: Adsorption; Biocompatible Materials; Biofouling; Cell Survival; Chemistry Techniques, Synthetic; Ethyldimethylaminopropyl Carbodiimide; Fibrinogen; Glutamic Acid; Hemolysis; Human Umbilical Vein Endothelial Cells; Humans; Hydrochloric Acid; Immunoglobulin G; Lysine; Peptides; Triazoles | 2014 |
Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Clozapine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Excitatory Amino Acid Antagonists; Fluorobenzenes; GABA Agents; Gamma Rhythm; gamma-Aminobutyric Acid; Glutamic Acid; Haloperidol; Male; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Riluzole; Triazoles | 2014 |
Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism.
Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Apyrase; Cell Line; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Extracellular Space; Glutamic Acid; Lipopolysaccharides; Mice, Inbred C57BL; Microglia; Pyrimidines; Receptors, Adenosine A2; Triazoles | 2015 |
Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Topics: Animals; Astrocytes; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Homeostasis; Kainic Acid; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Psychomotor Disorders; Pyrimidines; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptosomes; Time Factors; Triazoles | 2015 |
Confined chromophores in tobacco mosaic virus to mimic green fluorescent protein.
Topics: Capsid Proteins; Ethylamines; Ethyldimethylaminopropyl Carbodiimide; Fluorescence; Fluorescent Dyes; Glutamic Acid; Green Fluorescent Proteins; Light; Molecular Mimicry; Tobacco Mosaic Virus; Triazoles; Viral Structures | 2015 |
Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Brain-Derived Neurotrophic Factor; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; In Vitro Techniques; Phenethylamines; Potassium; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Synaptosomes; Triazoles | 2015 |
Vectorization of agrochemicals: amino acid carriers are more efficient than sugar carriers to translocate phenylpyrrole conjugates in the Ricinus system.
Topics: Agrochemicals; Amino Acids; Biological Transport; Fungicides, Industrial; Glucose; Glutamic Acid; Phloem; Pyrroles; Ricinus; Sugars; Triazoles | 2018 |
GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile.
Topics: Acetylcholine; Animals; Dopamine; Female; Frontal Lobe; gamma-Aminobutyric Acid; Glutamic Acid; Gonadotropin-Releasing Hormone; Hippocampus; Hypothalamus; Letrozole; Neurotransmitter Agents; Nitriles; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Inbred Strains; Serotonin; Triazoles | 2018 |
Novel pentacyclic triterpenes exhibiting strong neuroprotective activity in SH-SY5Y cells in salsolinol- and glutamate-induced neurodegeneration models.
Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Isoquinolines; Membrane Potential, Mitochondrial; Models, Biological; Molecular Structure; Neuroprotective Agents; Oxidative Stress; Structure-Activity Relationship; Triazoles; Triterpenes | 2021 |
MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice.
Topics: Adipose Tissue; Alkynes; Aminobutyrates; Animals; Anti-Obesity Agents; Appetite; Aspartic Acid; Disease Models, Animal; Drug Discovery; Glutamic Acid; Glycine; HEK293 Cells; Hepatocytes; Homeostasis; Humans; Insulin; Lactams; Male; Mice; Mice, Inbred C57BL; Obesity; Rats; Receptors, Pituitary Hormone; Structure-Activity Relationship; Tissue Distribution; Triazoles | 2021 |
Synthesis, phloem mobility and induced plant resistance of synthetic salicylic acid amino acid or glucose conjugates.
Topics: Agrochemicals; Amino Acids; Fungicides, Industrial; Glucose; Glutamic Acid; Phloem; Plant Diseases; Salicylic Acid; Triazoles | 2022 |